Marked improvement of calcinosis in adult dermatomyositis with etidronate therapy

Hiroko Mori, Yosuke Okada, Kunihiro Yamaoka, Kazuyoshi Saito, Yoshiya Tanaka

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

We report a 26-year-old woman with severe calcinosis associated with dermatomyositis. Although calcinosis of the skin or muscles is unusual in adults with dermatomyositis, this patient developed subcutaneous calcinosis with tenderness on the arms, axillary areas, shoulder areas, chest, abdomen, pelvis, and limbs. The calcinosis steadily increased and spread until joint motions were severely limited. Radiographic examination showed extensive soft-tissue calcification with a reticular pattern and severe osteoporosis. The patient was treated with oral etidronate (800 mg/day for 3 months every 6 months) to prevent calcification of the lesions. Three months later, the patient showed a dramatic improvement in symptoms with softening of the calcinosis, reduced pain, and marked increase in joint mobility. Radiographic examination showed marked decreases in the size of the calcified lesions compared to pre-treatment findings, and this effect persisted with a constant progressive efficacy for 3 years. The 3-year course of etidronate therapy also resulted in marked improvement of the severe osteoporosis and the patient was able to return to work and enjoy a normal life. We propose etidronate as a beneficial and effective therapy for calcinosis with osteoporosis.

Original languageEnglish
Pages (from-to)114-118
Number of pages5
JournalJournal of Bone and Mineral Metabolism
Volume30
Issue number1
DOIs
Publication statusPublished - 2012 Jan
Externally publishedYes

Fingerprint

Etidronic Acid
Calcinosis
Dermatomyositis
Osteoporosis
Therapeutics
Joints
Return to Work
Pelvis
Abdomen
Arm
Thorax
Extremities
Pain
Muscles
Skin

Keywords

  • Calcinosis
  • Dermatomyositis
  • Etidronate
  • Osteoporosis
  • Soft-tissue calcification

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Orthopedics and Sports Medicine

Cite this

Marked improvement of calcinosis in adult dermatomyositis with etidronate therapy. / Mori, Hiroko; Okada, Yosuke; Yamaoka, Kunihiro; Saito, Kazuyoshi; Tanaka, Yoshiya.

In: Journal of Bone and Mineral Metabolism, Vol. 30, No. 1, 01.2012, p. 114-118.

Research output: Contribution to journalArticle

Mori, Hiroko ; Okada, Yosuke ; Yamaoka, Kunihiro ; Saito, Kazuyoshi ; Tanaka, Yoshiya. / Marked improvement of calcinosis in adult dermatomyositis with etidronate therapy. In: Journal of Bone and Mineral Metabolism. 2012 ; Vol. 30, No. 1. pp. 114-118.
@article{6947309b71b14ce3aad37cf56fa447df,
title = "Marked improvement of calcinosis in adult dermatomyositis with etidronate therapy",
abstract = "We report a 26-year-old woman with severe calcinosis associated with dermatomyositis. Although calcinosis of the skin or muscles is unusual in adults with dermatomyositis, this patient developed subcutaneous calcinosis with tenderness on the arms, axillary areas, shoulder areas, chest, abdomen, pelvis, and limbs. The calcinosis steadily increased and spread until joint motions were severely limited. Radiographic examination showed extensive soft-tissue calcification with a reticular pattern and severe osteoporosis. The patient was treated with oral etidronate (800 mg/day for 3 months every 6 months) to prevent calcification of the lesions. Three months later, the patient showed a dramatic improvement in symptoms with softening of the calcinosis, reduced pain, and marked increase in joint mobility. Radiographic examination showed marked decreases in the size of the calcified lesions compared to pre-treatment findings, and this effect persisted with a constant progressive efficacy for 3 years. The 3-year course of etidronate therapy also resulted in marked improvement of the severe osteoporosis and the patient was able to return to work and enjoy a normal life. We propose etidronate as a beneficial and effective therapy for calcinosis with osteoporosis.",
keywords = "Calcinosis, Dermatomyositis, Etidronate, Osteoporosis, Soft-tissue calcification",
author = "Hiroko Mori and Yosuke Okada and Kunihiro Yamaoka and Kazuyoshi Saito and Yoshiya Tanaka",
year = "2012",
month = "1",
doi = "10.1007/s00774-011-0289-1",
language = "English",
volume = "30",
pages = "114--118",
journal = "Journal of Bone and Mineral Metabolism",
issn = "0914-8779",
publisher = "Springer Japan",
number = "1",

}

TY - JOUR

T1 - Marked improvement of calcinosis in adult dermatomyositis with etidronate therapy

AU - Mori, Hiroko

AU - Okada, Yosuke

AU - Yamaoka, Kunihiro

AU - Saito, Kazuyoshi

AU - Tanaka, Yoshiya

PY - 2012/1

Y1 - 2012/1

N2 - We report a 26-year-old woman with severe calcinosis associated with dermatomyositis. Although calcinosis of the skin or muscles is unusual in adults with dermatomyositis, this patient developed subcutaneous calcinosis with tenderness on the arms, axillary areas, shoulder areas, chest, abdomen, pelvis, and limbs. The calcinosis steadily increased and spread until joint motions were severely limited. Radiographic examination showed extensive soft-tissue calcification with a reticular pattern and severe osteoporosis. The patient was treated with oral etidronate (800 mg/day for 3 months every 6 months) to prevent calcification of the lesions. Three months later, the patient showed a dramatic improvement in symptoms with softening of the calcinosis, reduced pain, and marked increase in joint mobility. Radiographic examination showed marked decreases in the size of the calcified lesions compared to pre-treatment findings, and this effect persisted with a constant progressive efficacy for 3 years. The 3-year course of etidronate therapy also resulted in marked improvement of the severe osteoporosis and the patient was able to return to work and enjoy a normal life. We propose etidronate as a beneficial and effective therapy for calcinosis with osteoporosis.

AB - We report a 26-year-old woman with severe calcinosis associated with dermatomyositis. Although calcinosis of the skin or muscles is unusual in adults with dermatomyositis, this patient developed subcutaneous calcinosis with tenderness on the arms, axillary areas, shoulder areas, chest, abdomen, pelvis, and limbs. The calcinosis steadily increased and spread until joint motions were severely limited. Radiographic examination showed extensive soft-tissue calcification with a reticular pattern and severe osteoporosis. The patient was treated with oral etidronate (800 mg/day for 3 months every 6 months) to prevent calcification of the lesions. Three months later, the patient showed a dramatic improvement in symptoms with softening of the calcinosis, reduced pain, and marked increase in joint mobility. Radiographic examination showed marked decreases in the size of the calcified lesions compared to pre-treatment findings, and this effect persisted with a constant progressive efficacy for 3 years. The 3-year course of etidronate therapy also resulted in marked improvement of the severe osteoporosis and the patient was able to return to work and enjoy a normal life. We propose etidronate as a beneficial and effective therapy for calcinosis with osteoporosis.

KW - Calcinosis

KW - Dermatomyositis

KW - Etidronate

KW - Osteoporosis

KW - Soft-tissue calcification

UR - http://www.scopus.com/inward/record.url?scp=84863393495&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863393495&partnerID=8YFLogxK

U2 - 10.1007/s00774-011-0289-1

DO - 10.1007/s00774-011-0289-1

M3 - Article

VL - 30

SP - 114

EP - 118

JO - Journal of Bone and Mineral Metabolism

JF - Journal of Bone and Mineral Metabolism

SN - 0914-8779

IS - 1

ER -